A detailed history of Watts Gwilliam & Co., LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Watts Gwilliam & Co., LLC holds 1,592 shares of LLY stock, worth $1.25 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
1,592
Previous 1,495 6.49%
Holding current value
$1.25 Million
Previous $1.14 Billion 27.37%
% of portfolio
0.32%
Previous 0.35%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$772.14 - $960.02 $74,897 - $93,121
97 Added 6.49%
1,592 $1.45 Billion
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $885,339 - $1.18 Million
1,495 New
1,495 $1.14 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Watts Gwilliam & Co., LLC Portfolio

Follow Watts Gwilliam & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Watts Gwilliam & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Watts Gwilliam & Co., LLC with notifications on news.